39000276|t|SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2.
39000276|a|Neurologic manifestations are an immediate consequence of SARS-CoV-2 infection, the etiologic agent of COVID-19, which, however, may also trigger long-term neurological effects. Notably, COVID-19 patients with neurological symptoms show elevated levels of biomarkers associated with brain injury, including Tau proteins linked to Alzheimer's pathology. Studies in brain organoids revealed that SARS-CoV-2 alters the phosphorylation and distribution of Tau in infected neurons, but the mechanisms are currently unknown. We hypothesize that these pathological changes are due to the recruitment of Tau into stress granules (SGs) operated by the nucleocapsid protein (NCAP) of SARS-CoV-2. To test this hypothesis, we investigated whether NCAP interacts with Tau and localizes to SGs in hippocampal neurons in vitro and in vivo. Mechanistically, we tested whether SUMOylation, a posttranslational modification of NCAP and Tau, modulates their distribution in SGs and their pathological interaction. We found that NCAP and Tau colocalize and physically interact. We also found that NCAP induces hyperphosphorylation of Tau and causes cognitive impairment in mice infected with NCAP in their hippocampus. Finally, we found that SUMOylation modulates NCAP SG formation in vitro and cognitive performance in infected mice. Our data demonstrate that NCAP induces Tau pathological changes both in vitro and in vivo. Moreover, we demonstrate that SUMO2 ameliorates NCAP-induced Tau pathology, highlighting the importance of the SUMOylation pathway as a target of intervention against neurotoxic insults, such as Tau oligomers and viral infection.
39000276	0	10	SARS-CoV-2	Species	2697049
39000276	11	31	Nucleocapsid Protein	Gene	
39000276	40	43	Tau	Gene	4137
39000276	93	98	SUMO2	Gene	6613
39000276	158	178	SARS-CoV-2 infection	Disease	MESH:D000086382
39000276	203	211	COVID-19	Disease	MESH:D000086382
39000276	287	295	COVID-19	Disease	MESH:D000086382
39000276	296	304	patients	Species	9606
39000276	310	331	neurological symptoms	Disease	MESH:D009461
39000276	383	395	brain injury	Disease	MESH:D001930
39000276	407	410	Tau	Gene	4137
39000276	430	441	Alzheimer's	Disease	MESH:D000544
39000276	494	504	SARS-CoV-2	Species	2697049
39000276	552	555	Tau	Gene	4137
39000276	696	699	Tau	Gene	4137
39000276	743	763	nucleocapsid protein	Gene	
39000276	765	769	NCAP	Gene	
39000276	774	784	SARS-CoV-2	Species	2697049
39000276	835	839	NCAP	Gene	
39000276	855	858	Tau	Gene	4137
39000276	1009	1013	NCAP	Gene	
39000276	1018	1021	Tau	Gene	4137
39000276	1109	1113	NCAP	Gene	
39000276	1118	1121	Tau	Gene	4137
39000276	1177	1181	NCAP	Gene	
39000276	1214	1217	Tau	Gene	4137
39000276	1229	1249	cognitive impairment	Disease	MESH:D003072
39000276	1253	1257	mice	Species	10090
39000276	1272	1276	NCAP	Gene	
39000276	1344	1348	NCAP	Gene	
39000276	1409	1413	mice	Species	10090
39000276	1441	1445	NCAP	Gene	
39000276	1454	1457	Tau	Gene	4137
39000276	1536	1541	SUMO2	Gene	6613
39000276	1554	1558	NCAP	Gene	
39000276	1567	1570	Tau	Gene	4137
39000276	1673	1683	neurotoxic	Disease	MESH:D020258
39000276	1701	1704	Tau	Gene	4137
39000276	1719	1734	viral infection	Disease	MESH:D014777
39000276	Negative_Correlation	4137	6613
39000276	Association	MESH:D009461	4137
39000276	Association	MESH:D000544	4137
39000276	Association	MESH:D014777	6613
39000276	Association	MESH:D000086382	6613
39000276	Association	MESH:D000086382	4137

